Fulgent Genetics (FLGT) Competitors $17.86 -0.46 (-2.51%) Closing price 04/17/2025 04:00 PM EasternExtended Trading$17.84 -0.02 (-0.11%) As of 04/17/2025 06:13 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock FLGT vs. AGL, PGNY, ADUS, ARDT, NHC, PACS, TDOC, AHCO, VRDN, and CDNAShould you be buying Fulgent Genetics stock or one of its competitors? The main competitors of Fulgent Genetics include agilon health (AGL), Progyny (PGNY), Addus HomeCare (ADUS), Ardent Health Partners (ARDT), National HealthCare (NHC), PACS Group (PACS), Teladoc Health (TDOC), AdaptHealth (AHCO), Viridian Therapeutics (VRDN), and CareDx (CDNA). These companies are all part of the "healthcare" industry. Fulgent Genetics vs. agilon health Progyny Addus HomeCare Ardent Health Partners National HealthCare PACS Group Teladoc Health AdaptHealth Viridian Therapeutics CareDx Fulgent Genetics (NASDAQ:FLGT) and agilon health (NYSE:AGL) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, analyst recommendations, earnings, risk, profitability, media sentiment, valuation, community ranking and institutional ownership. Do institutionals & insiders hold more shares of FLGT or AGL? 48.1% of Fulgent Genetics shares are owned by institutional investors. 31.8% of Fulgent Genetics shares are owned by insiders. Comparatively, 3.2% of agilon health shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Which has more risk and volatility, FLGT or AGL? Fulgent Genetics has a beta of 1.36, indicating that its share price is 36% more volatile than the S&P 500. Comparatively, agilon health has a beta of 0.38, indicating that its share price is 62% less volatile than the S&P 500. Which has preferable earnings and valuation, FLGT or AGL? Fulgent Genetics has higher earnings, but lower revenue than agilon health. Fulgent Genetics is trading at a lower price-to-earnings ratio than agilon health, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioFulgent Genetics$283.47M1.94-$167.82M-$1.41-12.67agilon health$6.06B0.27-$262.60M-$0.63-6.39 Does the media favor FLGT or AGL? In the previous week, agilon health had 9 more articles in the media than Fulgent Genetics. MarketBeat recorded 12 mentions for agilon health and 3 mentions for Fulgent Genetics. Fulgent Genetics' average media sentiment score of 1.29 beat agilon health's score of 0.49 indicating that Fulgent Genetics is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Fulgent Genetics 3 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive agilon health 4 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 3 Negative mention(s) 0 Very Negative mention(s) Neutral Does the MarketBeat Community prefer FLGT or AGL? Fulgent Genetics received 190 more outperform votes than agilon health when rated by MarketBeat users. Likewise, 59.80% of users gave Fulgent Genetics an outperform vote while only 43.90% of users gave agilon health an outperform vote. CompanyUnderperformOutperformFulgent GeneticsOutperform Votes24459.80% Underperform Votes16440.20% agilon healthOutperform Votes5443.90% Underperform Votes6956.10% Is FLGT or AGL more profitable? agilon health has a net margin of -6.88% compared to Fulgent Genetics' net margin of -59.39%. Fulgent Genetics' return on equity of -1.81% beat agilon health's return on equity.Company Net Margins Return on Equity Return on Assets Fulgent Genetics-59.39% -1.81% -1.66% agilon health -6.88%-47.84%-14.97% Do analysts prefer FLGT or AGL? Fulgent Genetics presently has a consensus target price of $16.00, suggesting a potential downside of 10.41%. agilon health has a consensus target price of $4.60, suggesting a potential upside of 14.22%. Given agilon health's stronger consensus rating and higher possible upside, analysts clearly believe agilon health is more favorable than Fulgent Genetics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Fulgent Genetics 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00agilon health 2 Sell rating(s) 13 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.06 SummaryFulgent Genetics beats agilon health on 11 of the 18 factors compared between the two stocks. Get Fulgent Genetics News Delivered to You Automatically Sign up to receive the latest news and ratings for FLGT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart FLGT vs. The Competition Export to ExcelMetricFulgent GeneticsMedical laboratories IndustryMedical SectorNASDAQ ExchangeMarket Cap$551.27M$2.78B$5.30B$7.35BDividend YieldN/A31.35%5.45%4.30%P/E Ratio-3.2414.4621.8617.81Price / Sales1.94192.58380.6697.70Price / Cash5.1257.5638.2634.64Price / Book0.474.486.453.98Net Income-$167.82M-$22.21M$3.22B$247.81M1 Month Performance5.87%-8.37%-9.76%-7.94%1 Year Performance-12.28%7.26%11.49%1.52% Fulgent Genetics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)FLGTFulgent Genetics3.5294 of 5 stars$17.86-2.5%$16.00-10.4%-11.2%$551.27M$283.47M-3.241,010Positive NewsAGLagilon health1.684 of 5 stars$5.60-1.4%$4.37-22.0%-25.3%$2.31B$6.06B-5.96650Analyst ForecastGap DownPGNYProgyny2.3938 of 5 stars$22.08-1.2%$23.64+7.0%-32.7%$1.89B$1.17B38.07310Short Interest ↓News CoveragePositive NewsADUSAddus HomeCare4.5828 of 5 stars$102.17+1.3%$132.78+30.0%+4.2%$1.86B$1.15B23.3833,200Positive NewsARDTArdent Health PartnersN/A$12.52+6.3%$20.58+64.4%N/A$1.79B$5.97B0.0024,200Positive NewsNHCNational HealthCareN/A$92.33+0.5%N/AN/A$1.43B$1.30B11.5712,400News CoveragePositive NewsPACSPACS Group3.2473 of 5 stars$9.33+1.9%$34.00+264.4%-59.8%$1.42B$3.56B0.0032,433TDOCTeladoc Health3.7402 of 5 stars$7.25flat$10.94+50.9%-48.2%$1.27B$2.57B-1.265,100Short Interest ↓AHCOAdaptHealth3.6328 of 5 stars$8.22-5.1%$13.80+67.9%-16.8%$1.11B$3.26B-4.9810,900VRDNViridian Therapeutics1.1642 of 5 stars$13.30+10.6%$35.70+168.4%-13.4%$1.08B$302,000.00-3.0950News CoveragePositive NewsCDNACareDx3.6672 of 5 stars$18.90+0.5%$31.83+68.4%+118.3%$1.05B$333.79M-7.00740Analyst ForecastNews CoveragePositive NewsGap Up Related Companies and Tools Related Companies AGL Competitors PGNY Competitors ADUS Competitors ARDT Competitors NHC Competitors PACS Competitors TDOC Competitors AHCO Competitors VRDN Competitors CDNA Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:FLGT) was last updated on 4/19/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredThe Crypto Market is About to Change LivesI've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fulgent Genetics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Fulgent Genetics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy FLGT Stock Free FLGT Stock Alerts